MTHFR gene polymorphism and severe toxicity during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil (CMF)

被引：73

作者：

Toffoli, G ^{[1
]}

Veronesi, A

Boiocchi, M

Crivellari, D

机构：

[1] Natl Canc Inst, Ctr Riferimento Oncol, Div Expt Oncol 1, Aviano, PN, Italy

[2] Natl Canc Inst, Ctr Riferimento Oncol, Div Med Oncol C, Aviano, PN, Italy

来源：

ANNALS OF ONCOLOGY | 2000年 / 11卷 / 03期

关键词：

D O I：

10.1023/A:1008337900349

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：373 / 374

页数：2

共 7 条

[1] A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells [J].

Bagley, PJ ;

Selhub, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (22) :13217-13220

[2] Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil [J].

Colleoni, M ;

Price, KN ;

Castiglione-Gertsch, M ;

Gelber, RD ;

Coates, AS ;

Goldhirsch, A .

LANCET, 1999, 354 (9173) :130-131

[3]

CRIVELLARI D, IN PRESS J CLIN ONCO

[4]

*EARLY BREAST CANC, 1998, EIKE, V352, P930

[5] Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence [J].

Eikelboom, JW ;

Lonn, E ;

Genest, J ;

Hankey, G ;

Yusuf, S .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) :363-375

[6] A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].

FROSST, P ;

BLOM, HJ ;

MILOS, R ;

GOYETTE, P ;

SHEPPARD, CA ;

MATTHEWS, RG ;

BOERS, GJH ;

DENHEIJER, M ;

KLUIJTMANS, LAJ ;

VANDENHEUVEL, LP ;

ROZEN, R .

NATURE GENETICS, 1995, 10 (01) :111-113

[7]

Morgan SL, 1998, J RHEUMATOL, V25, P441

← 1 →